Clinical Trial Update: Roxadustat in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison to Darbepoetin Alfa [Phase 3]

View source ↗

Summary

Phase 3 trial comparing roxadustat to darbepoetin alfa for treating anemia in non-dialysis chronic kidney disease patients; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• Roxadustat (roxadustat)
• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Anemia in Chronic Kidney Disease in Non-dialysis Patients | Phase 3 | Status: COMPLETED | Results posted: 2021-03-29